版本:
中国

BRIEF-NantKwest and Viracta Therapeutics report series B financing

April 4 NantKwest Inc:

* NantKwest and Viracta Therapeutics announce series b financing and immunotherapy partnership

* NantKwest - co, Viracta Therapeutics announced initial closing of a series b preferred financing round of up to $18.4 million with co as lead investor Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐